These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32712248)

  • 21. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
    White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
    Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paxillin regulated genomic networks in prostate cancer.
    Ma X; Biswas A; Hammes SR
    Steroids; 2019 Nov; 151():108463. PubMed ID: 31344408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
    Wang T; Abou-Ouf H; Hegazy SA; Alshalalfa M; Stoletov K; Lewis J; Donnelly B; Bismar TA
    J Mol Med (Berl); 2016 Dec; 94(12):1411-1422. PubMed ID: 27534968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
    Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
    Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
    Kim HJ; Park YI; Dong MS
    Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines.
    Orio F; Térouanne B; Georget V; Lumbroso S; Avances C; Siatka C; Sultan C
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):105-14. PubMed ID: 12573820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis.
    Tousignant KD; Rockstroh A; Taherian Fard A; Lehman ML; Wang C; McPherson SJ; Philp LK; Bartonicek N; Dinger ME; Nelson CC; Sadowski MC
    Mol Cancer Res; 2019 May; 17(5):1166-1179. PubMed ID: 30808729
    [No Abstract]   [Full Text] [Related]  

  • 29. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
    Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
    Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M
    Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells.
    Chung BH; Mitchell SH; Zhang JS; Young CY
    Carcinogenesis; 2001 Aug; 22(8):1201-6. PubMed ID: 11470750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer.
    Lee YG; Nam Y; Shin KJ; Yoon S; Park WS; Joung JY; Seo JK; Jang J; Lee S; Nam D; Caino MC; Suh PG; Chan Chae Y
    Cancer Lett; 2020 Feb; 471():72-87. PubMed ID: 31838085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. βKlotho inhibits androgen/androgen receptor‑associated epithelial‑mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling.
    Liu Z; Zhang H; Ding S; Qi S; Liu S; Sun D; Dong W; Yin L; Li M; Zhao X; Lu J
    Oncol Rep; 2018 Jul; 40(1):217-225. PubMed ID: 29749458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
    Katta S; Srivastava A; Thangapazham RL; Rosner IL; Cullen J; Li H; Sharad S
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
    Meng D; Yang S; Wan X; Zhang Y; Huang W; Zhao P; Li T; Wang L; Huang Y; Li T; Li Y
    Int J Biochem Cell Biol; 2016 Apr; 73():30-40. PubMed ID: 26827675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,25(OH)
    Abu El Maaty MA; Alborzinia H; Khan SJ; Büttner M; Wölfl S
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1618-1630. PubMed ID: 28651973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen regulation of gene expression.
    Lamont KR; Tindall DJ
    Adv Cancer Res; 2010; 107():137-62. PubMed ID: 20399963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic Comparison and MRM-Based Comparative Analysis of Metabolites Reveal Metabolic Shift in Human Prostate Cancer Cell Lines.
    Shu Q; Cai T; Chen X; Zhu HH; Xue P; Zhu N; Xie Z; Wei S; Zhang Q; Niu L; Gao WQ; Yang F
    J Proteome Res; 2015 Aug; 14(8):3390-402. PubMed ID: 26147661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular regulation of androgen action in prostate cancer.
    Dehm SM; Tindall DJ
    J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.
    Ide H; Lu Y; Yu J; China T; Kumamoto T; Koseki T; Yamaguchi R; Muto S; Horie S
    Prostate; 2012 Sep; 72(13):1407-11. PubMed ID: 22290195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.